SlideShare a Scribd company logo
Catalan Agency for Health Information, Assessment and
Quality (CAHIAQ) (www.aatrm.net)
WORKSHOP
Cooperation between patients and
health professionals organizations in
Health Technology Assessment
Anna Kotzeva, MD, MPH
4th EPF Regional Advocacy Seminar
Bucharest, 27-28 of October, 2011
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
1. Introductions of the participants (all, 10 min)
2. Objectives of the workshop
3. Overview: HTA process (presentation, 15 min)
4. Questions and discussion (all, 15 min)
5. Generation of recommendations (small group work, 30
min)
6. Selection of recommendations to report (all, 15 min)
Agenda
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 ARE YOU: Patient OR professional?
 DO YOU HAVE: Any knowledge of HTA process?
 DO YOU HAVE: Experience in HTA? In which way?
Introductions…
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 To understand What is HTA and Why it is important to both
patient and health professional organizations
 To explore the Roles of patient and health professional
organizations in HTA and the Possibilities for cooperation
 To identify the challenges for and barriers to patients-
professionals cooperation in the HTA area
 To formulate workable recommendations to ensure effective
patients-professionals cooperation in this area
Objectives and expected outcomes of the workshop
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
Health Technologies???
 Devices or equipments
(ex: pacemaker, glucometer)
 Procedures (ex: laparoscopy)
 Diagnostic tests
 Drugs
 Prevention programs
(ex: flu vaccination)
 New way of provision of clinical practice
(ex: teledermatology)
Health Technology Assessment (HTA): Overview
Assessment
 Consequences (short and long-
term) of using a technology
 Multidisciplinary process that
summarizes information about
clinical, economic, social, and
ethical issues
 Systematic, transparent,
unbiased, robust methodology
World of
research
World of
decision-
making
HTA has been compared to a
Battista RN. London, BMJ Publishing Group, 1996
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
Provides information to support decision-making
about priorities in healthcare
or
specific decisions about whether new treatments
should be introduced
Why to do HTA?
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 The assessment process and the way the assessment is used
varies from organization to organization
 It may be carried out to assess the available evidence to:
 simply better understand the clinical condition, or
 clarify the state of the art of the technology, or
 decide which treatments a healthcare system will pay for
 Scientific assessment – may be similar across settings
Appraisal – context-based, and may lead to different
decisions in different countries
How is HTA carried out?
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 Does the technology work?
 What benefit does it provide and for whom?
 What does it cost (to the healthcare service, to the patient,
etc.), including opportunity costs (what could be gained if the
funds were spent on alternative healthcare strategies)?
 How does it compare in terms of efficiency with the available
alternatives?
 Does it work in this healthcare setting? Should we do it here?
If so, how should we do it? (context!!!)
Examples of questions
Who needs HTA?
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 “Patient evidence” = experience-based knowledge on the
real effect of the illness AND of the treatment (health
technology) on all aspects of life
 HTA is similar to the process of taking decision on which
treatment to choose for particular patient
 Having knowledge on patient's needs and ensures better
adherence and the outcome of the treatment
Why patient experience is important?
The top
of the
iceberg
Introducing patients’ perspective to HTA could allow more
accurate assessment of the value of health technologies
The
iceberg
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
 Consultation: patients are approached to gather evidence
about their perspectives, experiences, or preferences about
technologies
 Participation: public or patient representatives participate in
different stages of the HTA process
 Prioritization of topics
 Scoping
 Evidence assessment
 Review
 Dissemination of findings
Types of public and patient involvement in HTA
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
Questions?
Discussion (all):
 Which must be the roles of patient and health
professional organizations in the process of HTA?
 How do you see the possibilities for cooperation?
 Do you expect any challenges for and barriers to
patients-professionals cooperation in the HTA area?
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
Small group work (30 min)
Group 1: Recommendations for effective and meaningful
cooperation between patient and professional organizations
Group 2: Recommendations for overcoming potential barriers
and difficulties in the cooperation between patient and
professional organizations
Group 3: Recommendations for the role of the EPF in this
cooperation
Key messages and recommendations

More Related Content

What's hot

Shared Decision Making in Health in Catalonia
Shared Decision Making in Health in CataloniaShared Decision Making in Health in Catalonia
Shared Decision Making in Health in Catalonia
Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
 
Jornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas BereczkyJornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas Bereczky
Instituto Aragonés de Ciencias de la Salud - IACS
 
Jornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma CasadoJornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma Casado
Instituto Aragonés de Ciencias de la Salud - IACS
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTA
Cochrane.Collaboration
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
Kathi Apostolidis
 
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
 
Path dias uk 250314
Path dias uk 250314Path dias uk 250314
Path dias uk 250314
Healthcare DENMARK
 
Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTA
EUPATI
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisions
EUPATI
 
Nurse Maude - Nursing documentation in an EHR
Nurse Maude - Nursing documentation in an EHRNurse Maude - Nursing documentation in an EHR
Nurse Maude - Nursing documentation in an EHR
Health Informatics New Zealand
 
The patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the NetherlandsThe patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the Netherlands
EUPATI
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.
EUPATI
 
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Office of Health Economics
 
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
Shared Patient Experience
 
Reg sapc 2008
Reg sapc 2008Reg sapc 2008
Reg sapc 2008pks4
 
Methods of nursing documentation final
Methods of nursing documentation finalMethods of nursing documentation final
Methods of nursing documentation finalTaghreed Hawsawi
 
Whitespace innovation study healthcare ecosystems
Whitespace innovation study healthcare ecosystemsWhitespace innovation study healthcare ecosystems
Whitespace innovation study healthcare ecosystems
Brand Acumen
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
ipposi
 
Clinical pathways
Clinical pathwaysClinical pathways
Clinical pathways
Ihsan ullah khamoosh
 
[1] documentation and reporting
[1] documentation and reporting[1] documentation and reporting
[1] documentation and reporting
Naveen Kumar Sharma
 

What's hot (20)

Shared Decision Making in Health in Catalonia
Shared Decision Making in Health in CataloniaShared Decision Making in Health in Catalonia
Shared Decision Making in Health in Catalonia
 
Jornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas BereczkyJornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas Bereczky
 
Jornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma CasadoJornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma Casado
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTA
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
 
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
The Registry Evaluation and Quality Standards Tool (REQUEST) for health techn...
 
Path dias uk 250314
Path dias uk 250314Path dias uk 250314
Path dias uk 250314
 
Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTA
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisions
 
Nurse Maude - Nursing documentation in an EHR
Nurse Maude - Nursing documentation in an EHRNurse Maude - Nursing documentation in an EHR
Nurse Maude - Nursing documentation in an EHR
 
The patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the NetherlandsThe patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the Netherlands
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.
 
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
 
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
How hospitals can used PatientReported experience questionnaire (PREM)? (EN)
 
Reg sapc 2008
Reg sapc 2008Reg sapc 2008
Reg sapc 2008
 
Methods of nursing documentation final
Methods of nursing documentation finalMethods of nursing documentation final
Methods of nursing documentation final
 
Whitespace innovation study healthcare ecosystems
Whitespace innovation study healthcare ecosystemsWhitespace innovation study healthcare ecosystems
Whitespace innovation study healthcare ecosystems
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
 
Clinical pathways
Clinical pathwaysClinical pathways
Clinical pathways
 
[1] documentation and reporting
[1] documentation and reporting[1] documentation and reporting
[1] documentation and reporting
 

Similar to HTA: Involvement of patients and professionals (workshop)

Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15
CADTH Symposium
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.
HTAi Bilbao 2012
 
eHealth and patient outcomes
eHealth and patient outcomeseHealth and patient outcomes
eHealth and patient outcomesAnna Kotzeva
 
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.REBRATSoficial
 
Jornadas #PatientInHTA · François Houyez
Jornadas #PatientInHTA · François Houyez Jornadas #PatientInHTA · François Houyez
Jornadas #PatientInHTA · François Houyez
Instituto Aragonés de Ciencias de la Salud - IACS
 
Dr. Davy Cheng
Dr. Davy ChengDr. Davy Cheng
Dr. Davy Chengichil
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
jangeissler
 
HTAi 2012 presentation in HTAi 2011
HTAi 2012 presentation in HTAi 2011HTAi 2012 presentation in HTAi 2011
HTAi 2012 presentation in HTAi 2011
HTAi Bilbao 2012
 
Why OMA... Why Now?
Why OMA... Why Now?Why OMA... Why Now?
Why OMA... Why Now?
3GDR
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMER
Yogesh Arora
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
ipposi
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum
 
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applicationsMAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applications
HTAi Bilbao 2012
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHAnna Kotzeva
 
2014 09-04 hta afrique banken final
2014 09-04 hta afrique banken final2014 09-04 hta afrique banken final
2014 09-04 hta afrique banken final
Reiner Banken
 
Cadth 2015 b2 slide show
Cadth 2015 b2 slide showCadth 2015 b2 slide show
Cadth 2015 b2 slide show
CADTH Symposium
 
Cadth 2015 a2 cadth international farup
Cadth 2015 a2 cadth international farupCadth 2015 a2 cadth international farup
Cadth 2015 a2 cadth international farup
CADTH Symposium
 
Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Gezonde scepsis
 
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
IBM Cúram Software Health and Social Programs
 

Similar to HTA: Involvement of patients and professionals (workshop) (20)

Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.
 
eHealth and patient outcomes
eHealth and patient outcomeseHealth and patient outcomes
eHealth and patient outcomes
 
Shu ti (sintesi)
Shu ti (sintesi)Shu ti (sintesi)
Shu ti (sintesi)
 
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
 
Jornadas #PatientInHTA · François Houyez
Jornadas #PatientInHTA · François Houyez Jornadas #PatientInHTA · François Houyez
Jornadas #PatientInHTA · François Houyez
 
Dr. Davy Cheng
Dr. Davy ChengDr. Davy Cheng
Dr. Davy Cheng
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
HTAi 2012 presentation in HTAi 2011
HTAi 2012 presentation in HTAi 2011HTAi 2012 presentation in HTAi 2011
HTAi 2012 presentation in HTAi 2011
 
Why OMA... Why Now?
Why OMA... Why Now?Why OMA... Why Now?
Why OMA... Why Now?
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMER
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
 
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applicationsMAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applications
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTH
 
2014 09-04 hta afrique banken final
2014 09-04 hta afrique banken final2014 09-04 hta afrique banken final
2014 09-04 hta afrique banken final
 
Cadth 2015 b2 slide show
Cadth 2015 b2 slide showCadth 2015 b2 slide show
Cadth 2015 b2 slide show
 
Cadth 2015 a2 cadth international farup
Cadth 2015 a2 cadth international farupCadth 2015 a2 cadth international farup
Cadth 2015 a2 cadth international farup
 
Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010
 
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

HTA: Involvement of patients and professionals (workshop)

  • 1. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) (www.aatrm.net) WORKSHOP Cooperation between patients and health professionals organizations in Health Technology Assessment Anna Kotzeva, MD, MPH 4th EPF Regional Advocacy Seminar Bucharest, 27-28 of October, 2011
  • 2. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) 1. Introductions of the participants (all, 10 min) 2. Objectives of the workshop 3. Overview: HTA process (presentation, 15 min) 4. Questions and discussion (all, 15 min) 5. Generation of recommendations (small group work, 30 min) 6. Selection of recommendations to report (all, 15 min) Agenda
  • 3. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  ARE YOU: Patient OR professional?  DO YOU HAVE: Any knowledge of HTA process?  DO YOU HAVE: Experience in HTA? In which way? Introductions…
  • 4. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  To understand What is HTA and Why it is important to both patient and health professional organizations  To explore the Roles of patient and health professional organizations in HTA and the Possibilities for cooperation  To identify the challenges for and barriers to patients- professionals cooperation in the HTA area  To formulate workable recommendations to ensure effective patients-professionals cooperation in this area Objectives and expected outcomes of the workshop
  • 5. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) Health Technologies???  Devices or equipments (ex: pacemaker, glucometer)  Procedures (ex: laparoscopy)  Diagnostic tests  Drugs  Prevention programs (ex: flu vaccination)  New way of provision of clinical practice (ex: teledermatology) Health Technology Assessment (HTA): Overview Assessment  Consequences (short and long- term) of using a technology  Multidisciplinary process that summarizes information about clinical, economic, social, and ethical issues  Systematic, transparent, unbiased, robust methodology
  • 6. World of research World of decision- making HTA has been compared to a Battista RN. London, BMJ Publishing Group, 1996
  • 7. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) Provides information to support decision-making about priorities in healthcare or specific decisions about whether new treatments should be introduced Why to do HTA?
  • 8. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  The assessment process and the way the assessment is used varies from organization to organization  It may be carried out to assess the available evidence to:  simply better understand the clinical condition, or  clarify the state of the art of the technology, or  decide which treatments a healthcare system will pay for  Scientific assessment – may be similar across settings Appraisal – context-based, and may lead to different decisions in different countries How is HTA carried out?
  • 9. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  Does the technology work?  What benefit does it provide and for whom?  What does it cost (to the healthcare service, to the patient, etc.), including opportunity costs (what could be gained if the funds were spent on alternative healthcare strategies)?  How does it compare in terms of efficiency with the available alternatives?  Does it work in this healthcare setting? Should we do it here? If so, how should we do it? (context!!!) Examples of questions
  • 11. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  “Patient evidence” = experience-based knowledge on the real effect of the illness AND of the treatment (health technology) on all aspects of life  HTA is similar to the process of taking decision on which treatment to choose for particular patient  Having knowledge on patient's needs and ensures better adherence and the outcome of the treatment Why patient experience is important?
  • 12. The top of the iceberg Introducing patients’ perspective to HTA could allow more accurate assessment of the value of health technologies
  • 14. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)  Consultation: patients are approached to gather evidence about their perspectives, experiences, or preferences about technologies  Participation: public or patient representatives participate in different stages of the HTA process  Prioritization of topics  Scoping  Evidence assessment  Review  Dissemination of findings Types of public and patient involvement in HTA
  • 15. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) Questions? Discussion (all):  Which must be the roles of patient and health professional organizations in the process of HTA?  How do you see the possibilities for cooperation?  Do you expect any challenges for and barriers to patients-professionals cooperation in the HTA area?
  • 16. Catalan Agency for Health Information, Assessment and Quality (CAHIAQ) Small group work (30 min) Group 1: Recommendations for effective and meaningful cooperation between patient and professional organizations Group 2: Recommendations for overcoming potential barriers and difficulties in the cooperation between patient and professional organizations Group 3: Recommendations for the role of the EPF in this cooperation Key messages and recommendations